Award
NIH Reporter #5K23DA055695-05
Injectable Extended-Release Buprenorphine (XR-B) in a Correctional Setting: A Pilot Randomized Controlled Trial
Recipient
Not specified
Award Amount
$195,696.00
Ceiling
$195,696.00
Awarded
June 03, 2026
Identifier
5K23DA055695-05
NIH/NIDA awarded a research project to study injectable extended-release buprenorphine in correctional settings through a pilot randomized controlled trial.
Description
A research study funded by NIH/NIDA to evaluate the effectiveness and implementation of injectable extended-release buprenorphine in a correctional setting. The project includes a randomized controlled trial and a process evaluation using implementation science frameworks.